GLP-1 Bridge in effect; prepare with protocol for patient wave
The GLP-1 Bridge demonstration program, through which eligible Part D beneficiaries can obtain semaglutide products for $50 a month, began on July 1. Prepare for what could be a large influx of visits and possibly confused requests with a clear understanding of the program parameters and billing alternatives.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.
Quick, Current, Complete - www.findacode.com